| Deanna Wallace, NP | |
|
1770 E Lake Shore Dr Ste 105, Decatur, IL 62521-3800 | |
| (217) 422-6100 | |
| (833) 784-5326 |
| Full Name | Deanna Wallace |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 1770 E Lake Shore Dr Ste 105, Decatur, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609222579 | NPI | - | NPPES |
| P01657319 | Other | IL | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 209.014278 (Illinois) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 209014278 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Hospital | Decatur, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prairie Cardiovascular Consultants Ltd | 3173435880 | 88 |
News Archive
After almost four years of negotiations, the WHO on Saturday announced it had reached an agreement on sharing flu virus samples, Agence-France Presse reports.
New research identifies a previously unknown enzymatic mechanism that subverts the early host immune response and promotes pathogenicity by manipulating a common signaling pathway in host cells.
News outlets look at the nuts and bolts of the health law's implementation, including a worry that coverage gaps will persist for some vulnerable people, as well as how the government pays for insurance subsidies and why some premium costs increase under the health law.
Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decision-making in clinical drug development, announced today that it has launched the Phoenix Pharmacometric Productivity Challenge, a competition to recognize excellence in the application of pharmacometric software to critical problems in drug development.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.
› Verified 2 days ago
| Entity Name | Prairie Cardiovascular Consultants Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982714218 PECOS PAC ID: 3173435880 Enrollment ID: O20031103000090 |
News Archive
After almost four years of negotiations, the WHO on Saturday announced it had reached an agreement on sharing flu virus samples, Agence-France Presse reports.
New research identifies a previously unknown enzymatic mechanism that subverts the early host immune response and promotes pathogenicity by manipulating a common signaling pathway in host cells.
News outlets look at the nuts and bolts of the health law's implementation, including a worry that coverage gaps will persist for some vulnerable people, as well as how the government pays for insurance subsidies and why some premium costs increase under the health law.
Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decision-making in clinical drug development, announced today that it has launched the Phoenix Pharmacometric Productivity Challenge, a competition to recognize excellence in the application of pharmacometric software to critical problems in drug development.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deanna Wallace, NP 1770 E Lake Shore Dr Ste 105, Decatur, IL 62521-3800 Ph: (217) 422-6100 | Deanna Wallace, NP 1770 E Lake Shore Dr Ste 105, Decatur, IL 62521-3800 Ph: (217) 422-6100 |
News Archive
After almost four years of negotiations, the WHO on Saturday announced it had reached an agreement on sharing flu virus samples, Agence-France Presse reports.
New research identifies a previously unknown enzymatic mechanism that subverts the early host immune response and promotes pathogenicity by manipulating a common signaling pathway in host cells.
News outlets look at the nuts and bolts of the health law's implementation, including a worry that coverage gaps will persist for some vulnerable people, as well as how the government pays for insurance subsidies and why some premium costs increase under the health law.
Pharsight, a market-leading provider of software and scientific consulting services to improve productivity and decision-making in clinical drug development, announced today that it has launched the Phoenix Pharmacometric Productivity Challenge, a competition to recognize excellence in the application of pharmacometric software to critical problems in drug development.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.
› Verified 2 days ago